Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy

@article{Dressler2018DefiningSA,
  title={Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy},
  author={Dirk W. Dressler and Roongroj Bhidayasiri and Saeed Bohlega and Pedro Chan{\'a} and Hsin Fen Chien and Tae Mo Chung and C. Colosimo and Markus Ebke and Klemens Fedoroff and Bernd Frank and Ryuji Kaji and Petr Kaňovsk{\'y} and Serdar Ibrahim Kocer and Federico Eduardo Micheli and Olga Orlova and S Paus and Zvezdan Pirtosek and Maja Relja and Raymond L. Rosales and Jos{\'e} Alberto Sag{\'a}stegui-Rodr{\'i}guez and Paul Walter Sch{\"o}nle and Gholam Ali Shahidi and Sofia L Timerbaeva and Uwe Walter and Fereshte Adib Saberi},
  journal={Journal of Neurology},
  year={2018},
  volume={265},
  pages={856-862}
}
Spasticity is a symptom occurring in many neurological conditions including stroke, multiple sclerosis, hypoxic brain damage, traumatic brain injury, tumours and heredodegenerative diseases. It affects large numbers of patients and may cause major disability. So far, spasticity has merely been described as part of the upper motor neurone syndrome or defined… CONTINUE READING